Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain
- PMID: 1839385
- DOI: 10.1016/0014-2999(91)90297-4
Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain
Abstract
The effect of chronic and acute treatment with desipramine (DMI) and electroconvulsive shock (ECS) on 5-hydroxytryptamine1A (5-HT1A) receptors was determined in the cortex and the hippocampus brain regions of rats. We observed that chronic treatment with both DMI and ECS significantly decreased 5-HT1A receptors, as determined by [3H]8-hydroxy-2-(di-n-propylamino)tetralin [( 3H]8-OH-DPAT) binding, in the cortex but not in the hippocampus. Acute treatment with DMI or ECS did not significantly alter the 5-HT1A receptors in the cortex. Neither chronic nor acute treatment influenced KD of [3H]8-OH-DPAT binding in the cortex or hippocampus. These results thus suggest that in contrast to the effects on 5-HT2 receptors, tricyclics as well as ECS produce similar effects on 5-HT1A receptors, suggesting that this site may represent a common site of action for antidepressant treatment.
Similar articles
-
Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.Neuropharmacology. 1992 Jan;31(1):25-32. doi: 10.1016/0028-3908(92)90156-j. Neuropharmacology. 1992. PMID: 1531864
-
Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.Mol Pharmacol. 1990 Feb;37(2):231-7. Mol Pharmacol. 1990. PMID: 1968223
-
Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat.Psychopharmacology (Berl). 1987;91(4):500-5. doi: 10.1007/BF00216018. Psychopharmacology (Berl). 1987. PMID: 2954178
-
Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters.Neuropharmacology. 1987 Jul;26(7B):815-22. doi: 10.1016/0028-3908(87)90057-8. Neuropharmacology. 1987. PMID: 2889156 Review.
-
Regulation of beta adrenergic and serotonin-S2 receptors in brain by electroconvulsive shock and serotonin.Psychopharmacol Ser. 1987;3:99-106. doi: 10.1007/978-3-642-71288-3_12. Psychopharmacol Ser. 1987. PMID: 3029757 Review. No abstract available.
Cited by
-
Effects of chronic treatment with valproate on serotonin-1A receptor binding and function.Psychopharmacology (Berl). 1994 Jan;113(3-4):539-42. doi: 10.1007/BF02245236. Psychopharmacology (Berl). 1994. PMID: 7862872
-
Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study.Psychopharmacology (Berl). 2005 Jun;179(4):781-90. doi: 10.1007/s00213-004-2122-1. Epub 2004 Dec 24. Psychopharmacology (Berl). 2005. PMID: 15619103
-
Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.Psychopharmacology (Berl). 1993;112(1):74-9. doi: 10.1007/BF02247365. Psychopharmacology (Berl). 1993. PMID: 7871012
-
Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression.Psychopharmacology (Berl). 1994 Mar;114(2):309-14. doi: 10.1007/BF02244853. Psychopharmacology (Berl). 1994. PMID: 7838924
-
Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.Psychopharmacology (Berl). 1995 Feb;117(3):358-63. doi: 10.1007/BF02246110. Psychopharmacology (Berl). 1995. PMID: 7770611
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources